| 3.09 0.01 (0.32%) | 04-24 15:58 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 3.94 |
1-year : | 4.6 |
| Resists | First : | 3.37 |
Second : | 3.94 |
| Pivot price | 3.07  |
|||
| Supports | First : | 2.97 |
Second : | 2.73 |
| MAs | MA(5) : | 3.03 |
MA(20) : | 3.07 |
| MA(100) : | 0 | MA(250) : | 0 | |
| MACD | MACD : | -0.2 |
Signal : | -0.2 |
| %K %D | K(14,3) : | 37 |
D(3) : | 22.6 |
| RSI | RSI(14): 45.1 |
|||
| 52-week | High : | 8.35 | Low : | 2.73 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ RGNT ] has closed below upper band by 42.7%. Bollinger Bands are 0% narrower than normal.
| If tomorrow: | Open lower | Open higher |
| High: | 3.18 - 3.19 | 3.19 - 3.2 |
| Low: | 2.7 - 2.71 | 2.71 - 2.73 |
| Close: | 3.07 - 3.09 | 3.09 - 3.11 |
Regentis Biomaterials Ltd., a regenerative medicine company, develops tissue repair solutions that restore the health and enhance quality of life of patients. Its lead product candidate is GelrinC, a cell-free, off-the-shelf hydrogel that is cured into an implant in the knee for the treatment of painful injuries and articular knee cartilage. The company focuses on developing orthopedic treatments using its Gelrin platform that is based on degradable hydrogel implants to regenerate damaged or diseased tissue. Regentis Biomaterials Ltd. was incorporated in 2004 and is based in Herzliya, Israel.
Sat, 18 Apr 2026
Pini Ben Elazar Net Worth (2026) - GuruFocus
Wed, 15 Apr 2026
Regentis Biomaterials (RGNT) Stock Upgrade Alert (+1.97%) 2026-04-15 - Volatility Breakout - Cổng thông tin điện tử tỉnh Tây Ninh
Wed, 01 Apr 2026
RGNT Stock Analysis: Regentis Biomaterials Ltd. Ordinary Shares dips 1.80% to $3 - Cổng thông tin điện tử Tỉnh Sơn La
Tue, 31 Mar 2026
RGNT SEC Filings - Regentis Biomaterials Ltd 10-K, 10-Q, 8-K Forms - Stock Titan
Fri, 16 Jan 2026
Regentis Hits New High; Is The Momentum Sustainable? - RTTNews
Mon, 08 Dec 2025
Regentis Biomaterials Commences Trading on NYSE: Set to Transform Cartilage Repair Market with Off-the-Shelf Regenerative Product - Newswire.com
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
AMEX
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Instruments & Supplies
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|